SEROPHENE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Serophene, and what generic alternatives are available?
Serophene is a drug marketed by Emd Serono and is included in one NDA.
The generic ingredient in SEROPHENE is clomiphene citrate. There are sixteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the clomiphene citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Serophene
A generic version of SEROPHENE was approved as clomiphene citrate by COSETTE on August 30th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SEROPHENE?
- What are the global sales for SEROPHENE?
- What is Average Wholesale Price for SEROPHENE?
Summary for SEROPHENE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 120 |
| Clinical Trials: | 6 |
| Patent Applications: | 72 |
| DailyMed Link: | SEROPHENE at DailyMed |
Recent Clinical Trials for SEROPHENE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Johns Hopkins University | Phase 1 |
| Yale University | Phase 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 1 |
US Patents and Regulatory Information for SEROPHENE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emd Serono | SEROPHENE | clomiphene citrate | TABLET;ORAL | 018361-001 | Mar 22, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
